1,730
Views
16
CrossRef citations to date
0
Altmetric
Research Article

A risk stratifying tool to facilitate safe late-stage percutaneous endoscopic gastrostomy in ALS

, , , , , , , , & show all
Pages 243-248 | Received 06 Oct 2016, Accepted 10 Dec 2016, Published online: 19 Jan 2017

References

  • Marin B, Desport JC, Kajeu P, Jesus P, Nicolaud B, Nicol M, et al. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry. 2011;82:628–34.
  • Wills AM, Hubbard J, Macklin EA, Glass J, Tandan R, Simpson EP, et al. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet. 2014;383:2065–72.
  • Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, et al. Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol. 2009;256:1236–42.
  • Chio A, Mora G, Leone M, Mazzini L, Cocito D, Giordana MT, et al. Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology. 2002;59:99–103.
  • Kasarskis EJ, Scarlata D, Hill R, Fuller C, Stambler N, Cedarbaum JM. A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials. J Neurol Sci. 1999;169:118–25.
  • Diagnosis ETFo, Management of Amyotrophic Lateral Sclerosis, Andersen PM, Abrahams S, Borasio GD, de Carvalho M, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)–revised report of an EFNS task force. Eur J Neurol. 2012;19:360–75.
  • Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73:1218–26.
  • ProGas Study Group. Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): a prospective cohort study. Lancet Neurol. 2015;14:702–9.
  • Westaby D, Young A, O'Toole P, Smith G, Sanders DS. The provision of a percutaneously placed enteral tube feeding service. Gut. 2010;59:1592–605.
  • Allen JA, Chen R, Ajroud-Driss S, Sufit RL, Heller S, Siddique T, et al. Gastrostomy tube placement by endoscopy versus radiologic methods in patients with ALS: a retrospective study of complications and outcome. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:308–14.
  • Stavroulakis T, Walsh T, Shaw PJ, McDermott CJ, Progas S. Gastrostomy use in motor neurone disease (MND): a review, meta-analysis and survey of current practice. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:96–104.
  • Marsden R, Millard E, Allan PJ, Blackwell V, East J, Lawson C, et al. Nutritional pathway for people with motor neurone disease. Br J Commun Nurs. 2016;21:260–3.
  • Oliver DJ, Turner MR. Some difficult decisions in ALS/MND. Amyotroph Lateral Scler 2010;11:339–43.
  • Chio A, Galletti R, Finocchiaro C, Righi D, Ruffino MA, Calvo A, et al. Percutaneous radiological gastrostomy: a safe and effective method of nutritional tube placement in advanced ALS. J Neurol Neurosurg Psychiatry. 2004;75:645–7.
  • Desport JC, Mabrouk T, Bouillet P, Perna A, Preux PM, Couratier P. Complications and survival following radiologically and endoscopically-guided gastrostomy in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005;6:88–93.
  • Rio A, Ampong MA, Turner MR, Shaw AS, Al-Chalabi A, Shaw CE, et al. Comparison of two percutaneous radiological gastrostomy tubes in the nutritional management of ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005;6:177–81.